Seven Medical Facilities Designated ‘Centers of Excellence’ for the Diagnosis and Management of Inflammatory Neuropathy by the GBS/CIDP Foundation International
NARBERTH, Pa., June 23 /PRNewswire/ — The GBS/CIDP Foundation International today announced the designation of seven initial “Centers of Excellence” for the diagnosis and treatment of Guillain-Barre syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and variants.
The centers will form a network of healthcare facilities to provide expert diagnosis and management of inflammatory neuropathies for patients who are unable to consult with medical experts in the field in their own communities.
“This is the first round of designations,” said Patricia A. Bryant, executive director of the foundation. “We will be accepting and evaluating applications from other interested institutions in the future in our efforts to better serve patients with these debilitating diseases.”
Heinrich-Heine University Department of Neurology, Germany Phoenix Neurological Associates/Banner Good Samaritan Medical Center, Arizona St. Elizabeth's Medical Center, Massachusetts The Johns Hopkins University School of Medicine, Maryland University of Kansas Medical Center, Kansas University of Texas Health Science Center, Texas Wayne State University School of Medicine, Detroit Medical Center, Michigan
Additional information about the centers and designation applications can be found on the Foundation’s web site: www.gbs-cidp.org.
The Foundation is a non-profit 501(c)(3) organization founded by Estelle and Robert Benson in 1980 as a means of helping others deal with these frightening disorders. Since its inception 30 years ago by a handful of volunteers, this grass roots effort has become an international organization with 30,000 members in 180 chapters in 30 countries.
For Further Information, contact: --------------------------------- Patricia A. Bryant Executive Director 610-667-0131 Patricia.email@example.com
SOURCE GBS/CIPD Foundation International